TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511
- PMID: 12384377
- PMCID: PMC128718
- DOI: 10.1128/AAC.46.11.3627-3629.2002
TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511
Abstract
Clinical isolate Escherichia coli BM4511 was resistant to broad-spectrum penicillins in the presence or in the absence of beta-lactamase inhibitors but remained susceptible to cephalosporins. Resistance was due to production of a new TEM-type beta-lactamase, designated TEM-103/IRT-28, characterized by the Arg(275)Leu substitution and encoded by the ca. 62-kb pIP845 conjugative plasmid of the IncI1 incompatibility group.
Similar articles
-
β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.Rev Argent Microbiol. 2014 Jul-Sep;46(3):210-7. doi: 10.1016/S0325-7541(14)70075-6. Epub 2014 Oct 15. Rev Argent Microbiol. 2014. PMID: 25444130
-
Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.Antimicrob Agents Chemother. 2004 May;48(5):1520-5. doi: 10.1128/AAC.48.5.1520-1525.2004. Antimicrob Agents Chemother. 2004. PMID: 15105100 Free PMC article.
-
Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.Antimicrob Agents Chemother. 2000 Oct;44(10):2709-14. doi: 10.1128/AAC.44.10.2709-2714.2000. Antimicrob Agents Chemother. 2000. PMID: 10991849 Free PMC article.
-
β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.Diagn Microbiol Infect Dis. 2013 Aug;76(4):532-3. doi: 10.1016/j.diagmicrobio.2013.04.015. Epub 2013 May 29. Diagn Microbiol Infect Dis. 2013. PMID: 23726651
-
Molecular characterization of amoxicillin-clavulanate resistance in a clinical isolate of Escherichia coli.Microb Drug Resist. 2002 Winter;8(4):267-72. doi: 10.1089/10766290260469525. Microb Drug Resist. 2002. PMID: 12523623
Cited by
-
Three decades of beta-lactamase inhibitors.Clin Microbiol Rev. 2010 Jan;23(1):160-201. doi: 10.1128/CMR.00037-09. Clin Microbiol Rev. 2010. PMID: 20065329 Free PMC article. Review.
-
Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.Antimicrob Agents Chemother. 2012 Feb;56(2):1101-4. doi: 10.1128/AAC.05079-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106220 Free PMC article.
-
Quantifying nonspecific TEM beta-lactamase (blaTEM) genes in a wastewater stream.Appl Environ Microbiol. 2009 Jan;75(1):203-11. doi: 10.1128/AEM.01254-08. Epub 2008 Nov 7. Appl Environ Microbiol. 2009. PMID: 18997031 Free PMC article.
-
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.Antimicrob Agents Chemother. 2004 Dec;48(12):4528-31. doi: 10.1128/AAC.48.12.4528-4531.2004. Antimicrob Agents Chemother. 2004. PMID: 15561821 Free PMC article.
References
-
- Bonomo, R. A., S. A. Rudin, and D. M. Shlaes. 1997. Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases. FEMS Microbiol. Lett. 148:59-62. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources